[Life expectancy of patients with resected bronchial carcinoma and postoperative cytostatic therapy using trenimon, cealysin, and viscum album].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D014784:Mistletoe; D010946:Plants, Medicinal; D011182:Postoperative Care; D011379:Prognosis; D014227:Triazines / Q000627:therapeutic use; D014228:Triaziquone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014227:Triazines; D014228:Triaziquone
Die Lebenserwartung der Patienten mit reseziertem Bronchialcarcinom nach postoperativer cytostatischer Nachbehandlung mit Trenimon, Cealysin und Viscum album.